Value of contrast ultrasonography in the detection of significant prostate cancer: Correlation with radical prostatectomy specimens

被引:25
作者
Sedelaar, JPM
van Leenders, GJLH
Goossen, TEB
Hulsbergen-van der Kaa, CA
van Adrichem, NP
Wijkstra, H
de la Rosette, JJMCH
机构
[1] Univ Nijmegen, Dept Urol, Med Ctr St Radboud, UMC Nijmegen, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Dept Pathol, Med Ctr St Radboud, NL-6500 HB Nijmegen, Netherlands
[3] De Eemland Ziekenhuis, Dept Urol, Amersfoort, Netherlands
关键词
contrast ultrasonography; 3D-ultrasonography imaging; prostate cancer; imaging; histology;
D O I
10.1002/pros.10145
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. The presented study has investigated a possible improvement of imaging prostate cancer: three-dimensional contrast-enhanced power Doppler ultrasonography (3D-CE-PDU). METHODS. Seventy patients with biopsy proven prostate cancer and scheduled for radical retropubic prostatectomy received a 3D-CE-PDU investigation before surgery. Two experts analyzed the ultrasound images. The ultrasound images were correlated to the whole-mount sections of the prostate specimen. The correlation protocol consisted of three evaluation steps. RESULTS. In total, 153 prostate tumors were found in the 70 prostate specimens: 61 tumors <5 mm, 93 tumors greater than or equal to5 mm. The diagnosis of clinical significant and insignificant prostate cancer was made in 85 and 88% of the patients for expert I and II, respectively. Diagnosis by imaging improved from 61% (43 of 70 of the prostate cancers) for standard detection tools to an average 86% (60 of 70 prostate cancers) for 3D-CE-PDU. CONCLUSION. 3D-CE-PDU improves the detection of prostate cancer in this group of prostate cancer patients. The use of 3D-CE-PDU in the clinic is questionable as indications are still unclear.
引用
收藏
页码:246 / 253
页数:8
相关论文
共 24 条
  • [1] Blomley MJ, 1997, RADIOLOGY, V205, P598
  • [2] Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: Correlation with biopsy outcome
    Bogers, HA
    Sedelaar, JPM
    Beerlage, HP
    de la Rosette, JJMCH
    Debruyne, FMJ
    Wijkstra, H
    Aarnink, RG
    [J]. UROLOGY, 1999, 54 (01) : 97 - 104
  • [3] Twelve prostate biopsies detect significant cancer volumes (&gt; 0.5 mL)
    Brössner, C
    Bayer, G
    Madersbacher, S
    Kuber, W
    Klingler, C
    Pycha, A
    [J]. BJU INTERNATIONAL, 2000, 85 (06) : 705 - 707
  • [4] Ultrasonographic contrast media in the urinary tract
    Cosgrove, DO
    Kiely, P
    Williamson, R
    Blomley, MJK
    Eckersley, RJ
    [J]. BJU INTERNATIONAL, 2000, 86 : 11 - 17
  • [5] Douglas TH, 1997, PROSTATE, V32, P59
  • [6] The definition and preoperative prediction of clinically insignificant prostate cancer
    Dugan, JA
    Bostwick, DG
    Myers, RP
    Qian, JQ
    Bergstralh, EJ
    Oesterling, JE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (04): : 288 - 294
  • [7] Impalpable invisible stage tie prostate cancer: Characteristics and clinical relevance in 100 radical prostatectomy specimens - A different view
    Elgamal, AAA
    VanPoppel, HP
    VandeVoorde, WM
    VanDorpe, JA
    Oyen, RH
    Baert, LV
    [J]. JOURNAL OF UROLOGY, 1997, 157 (01) : 244 - 250
  • [8] Nonpalpable stage T1c prostate cancer: Prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings
    Epstein, JI
    Chan, DW
    Sokoll, LJ
    Walsh, PC
    Cox, JL
    Rittenhouse, H
    Wolfert, R
    Carter, HB
    [J]. JOURNAL OF UROLOGY, 1998, 160 (06) : 2407 - 2411
  • [9] Distinguishing clinically important from unimportant prostate cancers before treatment: Value of systematic biopsies
    Goto, Y
    Ohori, M
    Arakawa, A
    Kattan, MW
    Wheeler, TM
    Scardino, PT
    [J]. JOURNAL OF UROLOGY, 1996, 156 (03) : 1059 - 1063
  • [10] Prostate cancer: Contrast-enhanced US for detection
    Halpern, EJ
    Rosenberg, M
    Gomella, LG
    [J]. RADIOLOGY, 2001, 219 (01) : 219 - 225